Synthetic Psilocybin nears FDA review, signaling a potential shift in American mental healthcare
This story is part of The Trip, a CPR News series on Colorado’s new psychedelic movement. Read more here.A form...
This story is part of The Trip, a CPR News series on Colorado’s new psychedelic movement. Read more here.A form...
GE HealthCare secured exclusive worldwide commercialisation rights to flurpiridaz F 18 from Lantheus. Credit: GE HealthCare / Business Wire. GE...
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:...
FDA has sent a warning letter to a company that makes stem cell and platelet-rich plasma products -- for pets....